focus -WSS

focus

author：entertainment 2025-09-29 13:30:41 - browse：98

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Mindstrong's demise and the future of mental health care

WSS

FDA advisers vote against ALS treatment from BrainStorm

Study: New antibiotic targets gonorrhea as well as last existing drug

White House calls on federal agencies to crack down on AI abuses

FDA seeks to regulate lab

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

10 million people disenrolled from Medicaid over past six months

hotspot

focus

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Mindstrong's demise and the future of mental health care

Alkermes shareholders re

FDA approves potent Eli Lilly obesity drug, Zepbound

What does generative AI mean for health care? We asked experts

Abortion clinic in Cancun will cater to Americans

Psychedelics group wrestles with new pharma identity

Free speech concerns arise in wake of journal editor Eisen's firing

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Free speech concerns arise in wake of journal editor Eisen's firing

explore

The Sacklers, horror, and ‘The Fall of the House of Usher’

MoonLake credibility takes another hit with mid

Biotech incubator Curie.Bio graduates its first startup

Victims of gun violence feel impacts long after bullet wound

Paxlovid should be available without a positive Covid test

Victims of gun violence feel impacts long after bullet wound

hotspot

hotspot

focus

Wikipedia